Frequency and mechanism of Lewis antigen expression in human urinary bladder and colon carcinoma patients.

por Langkilde, N. C., Wolf, H., Meldgård, P., Orntoft, T. F.
Publicado 1991

Prognostic DNA Methylation Markers for Prostate Cancer

por Strand, Siri H., Orntoft, Torben F., Sorensen, Karina D.
Publicado 2014

Profile of differentially expressed genes mediated by the type III epidermal growth factor receptor mutation expressed in a small-cell lung cancer cell line

por Pedersen, M W, Thykjær, T, Ørntoft, T F, Damstrup, L, Poulsen, H S
Publicado 2001

Clusterin expression can be modulated by changes in TCF1-mediated Wnt signaling

por Schepeler, Troels, Mansilla, Francisco, Christensen, Lise L, Ørntoft, Torben F, Andersen, Claus L
Publicado 2007

Gene expression profiling of noninvasive primary urothelial tumours using microarrays

por Aaboe, M, Marcussen, N, Jensen, K M-E, Thykjaer, T, Dyrskjøt, L, Ørntoft, T F
Publicado 2005

Functional analysis of the mismatch repair system in bladder cancer

por Thykjaer, T, Christensen, M, Clark, A B, Hansen, L R T, Kunkel, T A, Ørntoft, T F
Publicado 2001

Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case–control study

por Ørntoft, Mai-Britt W., Nielsen, Hans J., Ørntoft, Torben F., Andersen, Claus L.
Publicado 2015

Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array

por Tørring, N, Borre, M, Sørensen, K D, Andersen, C L, Wiuf, C, Ørntoft, T F
Publicado 2007

Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma

por Dyrskjøt, L, Zieger, K, Kissow Lildal, T, Reinert, T, Gruselle, O, Coche, T, Borre, M, Ørntoft, T F
Publicado 2012

Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation

por Reinert, Thomas, Borre, Michael, Christiansen, Anders, Hermann, Gregers G., Ørntoft, Torben F., Dyrskjøt, Lars
Publicado 2012

High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer

por Laurberg, Jens Reumert, Jensen, Jørgen Bjerggaard, Schepeler, Troels, Borre, Michael, Ørntoft, Torben F, Dyrskjøt, Lars
Publicado 2014

Bioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder

por Herbsleb, Malene, Christensen, Ole F, Thykjaer, Thomas, Wiuf, Carsten, Borre, Michael, Ørntoft, Torben F, Dyrskjøt, Lars
Publicado 2008

Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer

por Andersen, J B, Aaboe, M, Borden, E C, Goloubeva, O G, Hassel, B A, Ørntoft, T F
Publicado 2006

Construction and validation of the APOCHIP, a spotted oligo-microarray for the study of beta-cell apoptosis

por Magnusson, Nils E, Cardozo, Alessandra K, Kruhøffer, Mogens, Eizirik, Decio L, Ørntoft, Torben F, Jensen, Jens L
Publicado 2005

Repression of KIAA1199 attenuates Wnt-signalling and decreases the proliferation of colon cancer cells

por Birkenkamp-Demtroder, K, Maghnouj, A, Mansilla, F, Thorsen, K, Andersen, C L, Øster, B, Hahn, S, Ørntoft, T F
Publicado 2011

Increased cell motility and invasion upon knockdown of lipolysis stimulated lipoprotein receptor (LSR) in SW780 bladder cancer cells

por Herbsleb, Malene, Birkenkamp-Demtroder, Karin, Thykjaer, Thomas, Wiuf, Carsten, Hein, Anne-Mette K, Ørntoft, Torben F, Dyrskjøt, Lars
Publicado 2008

Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs

por Jensen, Steffen G, Lamy, Philippe, Rasmussen, Mads H, Ostenfeld, Marie S, Dyrskjøt, Lars, Ørntoft, Torben F, Andersen, Claus L
Publicado 2011

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression

por Egerod, Frederikke Lihme, Bartels, Annette, Fristrup, Niels, Borre, Michael, Ørntoft, Torben F, Oleksiewicz, Martin B, Brünner, Nils, Dyrskjøt, Lars
Publicado 2009

Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

por Storebjerg, Tine Maj, Strand, Siri H., Høyer, Søren, Lynnerup, Anne-Sofie, Borre, Michael, Ørntoft, Torben F., Sørensen, Karina D.
Publicado 2018

Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies

por Haldrup, Christa, Pedersen, Anne L., Øgaard, Nadia, Strand, Siri H., Høyer, Søren, Borre, Michael, Ørntoft, Torben F., Sørensen, Karina D.
Publicado 2018